Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $147.6900 (0.18%) ($146.3100 - $148.0800) on Wed. Oct. 4, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.15% (three month average) | RSI | 31 | Latest Price | $147.6900(0.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.7% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) DIA(55%) IBB(52%) VYM(51%) XLF(50%) | Factors Impacting ABBV price | ABBV will decline at least -0.575% in a week (0% probabilities). VXX(-35%) VIXM(-32%) USO(-23%) TBT(-20%) BNDX(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.575% (StdDev 1.15%) | Hourly BBV | 0.4 () | Intraday Trend | 0.9% | | | |
|
Resistance Level | $151.32 | 5 Day Moving Average | $148.94(-0.84%) | 10 Day Moving Average | $151.1(-2.26%) | 20 Day Moving Average | $151.32(-2.4%) | To recent high | -4.5% | To recent low | 10.6% | Market Cap | $260.567b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |